Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Chord Therapeutics S.a.r.l.

Headquarters: Geneva, Switzerland
Website: N/A
Year Founded: 2014
Status: Acquired

BioCentury | Dec 21, 2021
Product Development

Dec. 20 Quick Takes: Merck KGaA acquires neurology company Chord 

Plus: Novavax gets EU nod, Moderna, Cytokinetics, Amgen and more
BioCentury | Oct 13, 2020
Finance

Chord launches with $16M to test MS drug cladribine in rare autoimmune disorders

Omega Funds is sole investor for Swiss start-up’s series A, reuniting firm with CEO Plitz 
Items per page:
1 - 2 of 2
Help Center
Username
Request a Demo
Request Training
Ask a Question